Novavax (NVAX) Shares Outstanding (Entity) (2010 - 2026)
Powered by 
Analysis
Novavax (NVAX) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Novavax | 1.67 Bn | 949.38 Mn | 42.45 Mn | 164.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 164.82 Mn |
| Mar 31, 2026 | 164.42 Mn |
| Dec 31, 2025 | 162.58 Mn |
| Sep 30, 2025 | 162.47 Mn |
| Jun 30, 2025 | 162.16 Mn |
| Mar 31, 2025 | 161.96 Mn |
| Dec 31, 2024 | 160.42 Mn |
| Sep 30, 2024 | 160.15 Mn |
| Jun 30, 2024 | 159.89 Mn |
| Mar 31, 2024 | 140.37 Mn |
| Dec 31, 2023 | 100.77 Mn |
| Sep 30, 2023 | 118.73 Mn |
| Jun 30, 2023 | 94.31 Mn |
| Mar 31, 2023 | 86.29 Mn |
| Dec 31, 2022 | 86.04 Mn |
| Sep 30, 2022 | 78.48 Mn |
| Jun 30, 2022 | 78.17 Mn |
| Mar 31, 2022 | 78.12 Mn |
| Dec 31, 2021 | 75.84 Mn |
| Sep 30, 2021 | 75.42 Mn |